COMMUNIQUÉS West-GlobeNewswire

Guerbet: Revenue at 30 June 2019
25/07/2019
Revenue of €400.6 million for the 1 st half of the year, in line with annual targets: +2.8% at current exchange rates +1.8% at constant exchange rates Villepinte, 25 July 2019 – Guerbet (FR0000032526 GBT), a global [...]
GUERBET : Chiffre d’affaires au 30 juin 2019
25/07/2019
Chiffre d’affaires sur le 1 er semestre de 400,6 M€, conforme aux objectifs annuels: +2,8% à taux de change courant +1,8% à taux de change constant (TCC) Villepinte, le 25 juillet 2019 - Guerbet (FR0000032526 GBT), [...]
Retail Cannabis Hits Kelowna Today Through Hobo Recreational Cannabis Store
25/07/2019
Grown here and sold here; for the first time since federal legalization, Kelowna residents will now have access to locally grown cannabis products KELOWNA, British Columbia, July 25, 2019 (GLOBE NEWSWIRE) -- Hobo [...]
Abeona Therapeutics Announces Positive Interim Data from the ABO-102 Phase 1/2 Gene Therapy Clinical Trial in MPS IIIA
25/07/2019
Neurocognitive development of youngest patients preserved 12-18 months post treatment; development scores remain within range of unaffected children Robust and sustained biomarker improvement across all dose cohorts [...]
INmune Bio Co-Founder and CEO Presents at 17th Annual Congress of International Drug Discovery Science & Technology 2019
25/07/2019
LA JOLLA, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today [...]
Allergan and Editas Medicine Initiate the Brilliance Phase 1/2 Clinical Trial of AGN-151587 (EDIT-101) for the Treatment of LCA10
25/07/2019
Expect first patient dosing in second half of 2019 DUBLIN, Ireland and CAMBRIDGE, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Editas Medicine, Inc. ( [...]
Achieve TMS East Celebrates the Opening of its Haverhill Location
25/07/2019
HAVERHILL, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Achieve TMS East, Massachusetts’ largest provider of deep TMS therapy for the treatment of Depression and OCD, is pleased to announce the opening of its newest center [...]
Reminder: Investor Conference Call Today July 25, 2019 Management to Provide Details on Generex Up-list and 1:1 Stock Dividend
25/07/2019
MIRAMAR, Fla., July 25, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced the following access information for its [...]
Acer Therapeutics to Host Conference Call and Webcast to Discuss Update on its Pipeline Programs
25/07/2019
Call to take place on Wednesday, July 31 at 11:00 am Eastern Time NEWTON, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development [...]
Progenics Pharmaceuticals Announces Collaboration with Veterans Affairs on the AI Research Program for Medical Image Analysis
25/07/2019
The collaboration with VA Greater Los Angeles Healthcare System is nation’s first to validate deep learning algorithms in medical imaging of veterans with prostate cancer NEW YORK and WASHINGTON, July 25, 2019 (GLOBE [...]
Driven Deliveries Inc. Partners with Mozen, to provide Direct to Consumer Cannabis Delivery Service
25/07/2019
The Company continues to expand direct to consumer business SAN DIEGO, July 25, 2019 (GLOBE NEWSWIRE) -- Driven, the online cannabis sales platform, marketing and home delivery leader announced today that it has [...]
Bill W. Colston Named to Fluidigm Board of Directors
25/07/2019
Senior Biotechnology Leader with Broad Expertise in Life Science and Digital Health SOUTH SAN FRANCISCO, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of [...]
Turning Point Therapeutics Names Carol Gallagher, Pharm.D. to its Board of Directors
25/07/2019
SAN DIEGO, July 25, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, today announced the appointment of Carol [...]
The Joint Corp. to Host Conference Call on Thursday, August 8 to Discuss Second Quarter 2019 Results
25/07/2019
SCOTTSDALE, Ariz., July 25, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it will report its second quarter 2019 financial [...]
EDAP TMS Pre-Announces Strong 98% Growth in HIFU sales in the Second Quarter 2019
25/07/2019
45% growth in total Q2 2019 revenue year-over-year 78% growth in HIFU sales year-to-date through June 30, 2019 Company to Report Second Quarter 2019 Financial Results on Wednesday, August 28, 2019 and to host conference [...]
Geron to Announce Second Quarter Financial Results on August 1, 2019
25/07/2019
MENLO PARK, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that it will release its second quarter 2019 financial results after the market closes on Thursday, August 1, 2019 [...]
Dermatology Experts Present Latest Information at 2019 AAD Summer Meeting
25/07/2019
NEW YORK, July 25, 2019 (GLOBE NEWSWIRE) -- The 2019 American Academy of Dermatology Summer Meeting will take place from July 25 to 28 at the New York Hilton Midtown. The meeting will feature the latest information on [...]
Rubius Therapeutics Appoints Kris Elverum as Senior Vice President of Business Development and Strategy
25/07/2019
CAMBRIDGE, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is generating red blood cells and bioengineering them into an entirely new [...]
Passage Bio Expands Executive Management Team
25/07/2019
Company appoints Jill Quigley, J.D., as Chief Operating Officer and Alex Fotopoulos as Chief Technical Officer PHILADELPHIA, July 25, 2019 (GLOBE NEWSWIRE) -- Passage Bio, a genetic medicines company developing AAV- [...]

Pages